MARKET

MIRM

MIRM

Mirum Pharmaceuticals
NASDAQ
102.19
-9.21
-8.26%
After Hours: 104.21 +2.03 +1.98% 17:07 05/15 EDT
OPEN
109.47
PREV CLOSE
111.39
HIGH
110.25
LOW
101.96
VOLUME
1.67M
TURNOVER
--
52 WEEK HIGH
114.99
52 WEEK LOW
42.89
MARKET CAP
6.23B
P/E (TTM)
-7.5111
1D
5D
1M
3M
1Y
5Y
1D
Leerink Partners Remains a Buy on Mirum Pharmaceuticals (MIRM)
TipRanks · 1d ago
MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 2d ago
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Reuters · 3d ago
MIRUM PHARMACEUTICALS INC <MIRM.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $154 FROM $150
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba
Reuters · 3d ago
BUZZ-Mirum Pharma dips on $600 mln convertible bond sale
Reuters · 3d ago
Mirum Pharmaceuticals prices $600M senior notes
Seeking Alpha · 4d ago
More
About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the treatment of rare diseases affecting children and adults. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States, Canada and Japan. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The Company is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Webull offers Mirum Pharmaceuticals Inc stock information, including NASDAQ: MIRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRM stock methods without spending real money on the virtual paper trading platform.